Industrial Biotechnology Briefing to Highlight Green InvestingFeb 21 2005
WASHINGTON, D.C. (February 21, 2005) -- Biotechnology has moved beyond the doctor’s office to impact even the fuel we put in our cars. That will be one of the messages delivered at the third... |
|
CMS Administrator Mark McClellan to Address BIO CEO & Investor ConferenceFeb 18 2005
WASHINGTON, D.C. (February 18, 2005) -- The administrator of the Centers for Medicare and Medicaid Services (CMS), Mark B. McClellan, M.D., Ph.D., will give a keynote address at the seventh... |
|
BIO Supports Stem Cell Research Enhancement ActFeb 16 2005
WASHINGTON, D.C. (February 16, 2005)—Jim Greenwood, president of the Biotechnology Industry Organization (BIO), issued the following statement on the proposed Stem Cell Research Enhancement Act:... |
|
Clinical Experts to Discuss Biotechnology’s Impact on New Medicine at BIO CEO & Investor ConferenceFeb 15 2005
WASHINGTON, D.C. (February 15, 2005) -- Leading clinical experts working in major disease areas will discuss the impact of biotechnology and its role in the future of medicine at the... |
|
BIO Applauds Dr. Lester Crawford’s Nomination As FDA CommissionerFeb 14 2005
WASHINGTON, D.C. (February 14, 2005) -- Jim Greenwood, president of the Biotechnology Industry Organization (BIO) issued the following statement regarding President Bush’s intention to nominate... |
|
Pfizer Executive Peter Corr, Ph.D., to Deliver Keynote at BIO CEO & Investor ConferenceFeb 11 2005
WASHINGTON, D.C. (February 11, 2005) -- Peter B. Corr, Ph.D., Senior Vice President for Science and Technology at Pfizer, Inc., will make the keynote address for the luncheon on the second day... |
|
New BIO President Jim Greenwood to Address Investors and Industry LeadersFeb 10 2005
WASHINGTON, D.C. (February 10, 2005) -- New Biotechnology Industry Organization (BIO) President James C. Greenwood will share his vision of BIO on the opening day of the annual CEO & Investor... |
|
BIO to Host Wall Street Briefing on Novel Industrial BiotechnologyFeb 1 2005
WASHINGTON, D.C. (February 1, 2005) – The Biotechnology Industry Organization (BIO) will host the third annual briefing on industrial biotechnology for securities analysts and investors on Feb.... |
|
BIO Investor Conference Zeros in on Major Health Issues Including Cancer, Aging Diseases and ObesityJan 31 2005
WASHINGTON, D.C. (January 31, 2005) -- The Biotechnology Industry Organization’s (BIO) seventh annual CEO & Investor Conference will bring together biotechnology CEOs, investors and other key... |
|
Speakers to Address Government Policy and the Biotechnology Industry at BIO CEO & Investor Conference in FebruaryJan 19 2005
WASHINGTON, D.C. (January 19, 2005) -- Key regulatory and legislative issues will be the topic at the opening plenary session of the Biotechnology Industry Organization’s (BIO) seventh annual... |
